MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

NCT03321981 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer Metastatic

Interventions

DRUG: Zenocutuzumab
DRUG: Trastuzumab
DRUG: Vinorelbine
DRUG: Endocrine therapy

Sponsor

Merus B.V.